Nuclear Medicine: Page 331

Lack of IV contrast causes discrepancy in CT with PET scans

By Wayne Forrest

A study to determine the diagnostic limitations of low-dose, unenhanced CT scans performed for anatomic reference and attenuation correction during PET/CT has found that most discrepancies were due to the lack of intravenous contrast, which obscured liver metastases and lymph node recognition.

November 21, 2007

2007 11 21 16 05 05 706

Siemens makes FLT available to NCI research sites

By AuntMinnie.com staff writers

Siemens Medical Solutions said that the U.S. National Cancer Institute (NCI) has filed a cross-reference letter related to the company's investigational F-18 FLT imaging biomarker.

November 20, 2007

Dilon hires new sales VP

Scintimammography developer Dilon Technologies of Newport News, VA, has hired a new vice president in charge of sales and business development.

November 18, 2007

FDG-PET works for nose cancer staging, study finds

By Kate Madden Yee

FDG-PET can replace conventional workup in primary M staging of nonkeratinizing nasopharyngeal carcinoma (NPC), according to researchers at Chang Gung University College of Medicine in Taipei, Taiwan. The team compared the diagnostic efficacies of FDG-PET and CWU, as well as a combination of the two, in detecting distant metastasis.

November 14, 2007

2007 11 14 15 34 50 706

Eckert & Ziegler launch new gallium generator

By AuntMinnie.com staff writers

Radiotherapy and radiopharmaceutical developer Eckert & Ziegler Isotope Products introduced a new gallium-68 generator at last month's European Association of Nuclear Medicine (EANM) meeting in Copenhagen, Denmark.

November 12, 2007

256-slice perfusion CT equivalent to SPECT for arteriosclerosis detection

By Jerry Ingram

A prototype 256-slice multidetector-row CT (MDCT) scanner may be just as accurate as SPECT imaging for detecting atherosclerotic obstructions, according to data presented last week at the 2007 scientific sessions of the American Heart Association (AHA) in Orlando, FL.

November 12, 2007

International Isotopes Q3 sales edge up

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes of Idaho Falls, ID, reported slightly higher revenues and a bigger net loss for the company's third quarter.

November 11, 2007

Molecular Insight raises $150 million

By AuntMinnie.com staff writers

Molecular Insight Pharmaceuticals of Cambridge, MA, has raised $150 million in bonds due in 2012 with a group of institutional investors.

November 11, 2007

FDG-PET, MRI show worth in tumor treatment response

By Wayne Forrest

A research study from the University of Michigan in Ann Arbor finds that diffusion MRI and FDG-PET are two influential imaging biomarkers for quantifying tumor inflammatory response and macrophage infiltration after treatment.

November 1, 2007

Draxis Health's earnings take Q3 hit

By AuntMinnie.com staff writers

Canadian radiopharmaceutical developer Draxis Health of Mississauga, Ontario, reported declines in revenues and earnings in the company's financial results for the third quarter and first nine months of 2007.

October 31, 2007

Neoprobe cuts loss on higher sales

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe of Dublin, OH, this week reported that the company's net loss shrank in its third quarter (end-September 30) as revenues grew on stronger device sales.

October 30, 2007

Philips to show large-bore PET/CT at ASTRO

By AuntMinnie.com staff writers

Philips Medical Systems of Andover, MA, will unveil a new large-bore PET/CT system as a work-in-progress at this year's annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.

October 28, 2007

Page 331 of 438